Cart
sales@molnova.com
YD23
CAS No. 2951015-29-3
YD23( —— )
Catalog No. M37134 CAS No. 2951015-29-3
YD23 is a PROTAC that induces SMARCA2 degradation, has anticancer activity, and selectively inhibits the growth of SMARCA4 mutant lung cancer cells in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 155 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 503 | In Stock |
|
| 50MG | 790 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYD23
-
NoteResearch use only, not for human use.
-
Brief DescriptionYD23 is a PROTAC that induces SMARCA2 degradation, has anticancer activity, and selectively inhibits the growth of SMARCA4 mutant lung cancer cells in vitro.
-
DescriptionYD23 is a PROTAC that induces SMARCA2 degradation, has anticancer activity, and selectively inhibits the growth of SMARCA4 mutant lung cancer cells in vitro.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPROTACs | Epigenetic Reader Domain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2951015-29-3
-
Formula Weight738.76
-
Molecular FormulaC38H39FN8O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC(=O)C(N2C(=O)C=3C=CC=C(NCCOCCOC4=CC=C(C=C4F)CN5CCN(C=6C=C(N=NC6N)C7=CC=CC=C7O)CC5)C3C2=O)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PD128907 HCl
PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.
-
Pomalidomide-C2-acid
Pomalidomide-C2-acid is a PROTAC building block.
-
Nardoguaianone J
Nardoguaianone J, a guaiane-type compound, can be isolated from Nardostachys chinensis roots. Nardoguaianone J can enhance SERT activity.
